A notable increase in CD4+ and CD8+ T cells was observed in tumor-bearing mice treated with the chimeric virus, indicating that the chimeric virus rFlu-huCTLA4 can selectively target and kill HCC cells both in vivo and in vitro [68]. This evidence concerns the gene CD4 and neoplasm.